Data as of Nov 11, 2026

62.216.239.0/30

No anonymizer space · no proxy exits in 30 days

Equinix (EMEA) Acquisition Enterprises B.V.

Announcement
RPKI valid
Announced by
Type
Hosting
Risk
50 / 100 · Medium

Registrations in this block

The registry's network records over this block, widest first, each under its parent.

RangeAddressesNetnameHolderTypeCreatedAbuse contact
62.216.224.0/198,192NL-EQUINIXEMEA-20030519Equinix (EMEA) Acquisition Enterprises B.V. (ORG-TP3-RIPE) · NLALLOCATED PAMay 19, 2003smc@equinix.com
└ 62.216.239.0/304GLAXOSMITHKLINE_CONSUMER_HEALTHCARE_UK_TRADING_LIMITEDEquinix Customer - GlaxoSmithKline Consumer Healthcare (UK) Trading LimitedASSIGNED PAJun 22, 2023smc@equinix.com
via NL-EQUINIXEMEA-20030519

A contact marked “via” is the registry's: the record names none of its own, so the registry hands down its parent's.

Network & registry

Routing timeline

Who has announced 62.216.236.0/22

62.216.236.0/22

Routing history

Pattern
Stable
First seen
Oct 2006
Current origin since
Oct 2006 · 20 yr
Origin networks
1